Tokyo, Jan. 5 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060253) titled 'The Role of Pharmacist-Led Interventions in the Early Detection of Adverse Drug Reactions among People with Dementia and Their Families: A Scoping Review' on Jan. 5.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Tokyo University of Pharmacy and Life Sciences
Condition:
Condition - dementia (including Alzheimer's disease and other neurocognitive disorders)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We analysed studies that examined how pharmacist-led interventions (such as consultation, counselling, and monitoring) affect the recognition and early detection of adverse drug reactions among people with dementia and their families.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 1
years-old
=
Gender - Male and Female
Key inclusion criteria - Population: people with dementia and their families or caregivers
Concept: pharmacist involvement (consultation and support) with potential contribution to early detection of adverse drug reactions
Context: medication support settings in the community, including outpatient and home-based care
Key exclusion criteria - Research using languages other than Japanese or English.
Excluding review articles, commentaries, and conference proceedings.
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 11 Month 17 Day
Date of IRB - 2025 Year 11 Month 17 Day
Anticipated trial start date - 2025 Year 11 Month 17 Day
Last follow-up date - 2026 Year 01 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068918
Disclaimer: Curated by HT Syndication.
